This week, there is 1 drug in the patent and exclusivity list. It is: - BAUSCH AND LOMB INC's VYZULTA, containing active ingredient LATANOPROSTENE BUNOD Read More

With the development of chemotherapy agents, we've witnessed remarkable strides in the development of chemotherapy agents, resulting in improved efficacy and reduced side effects. However, a critical challenge persists that demands our attention: the management of chemotherapy-induced thrombocytopenia. Read More

This week, there are 4 drugs in the patent and exclusivity list. They are: - STEMLINE THERAPEUTICS INC's ORSERDU, containing active ingredient ELACESTRANT DIHYDROCHLORIDE - ABBVIE INC's UBRELVY, containing active ingredient UBROGEPANT - TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC's AUSTEDO, containing active ingredient DEUTETRABENAZINE - OTSUKA PHARMACEUTICAL CO LTD's REXULTI, containing active ingredient BREXPIPRAZOLE Read More

Thrombolytic drugs play a crucial role in treating various venous and arterial thromboembolic conditions, particularly acute myocardial infarction. Read More

This week, there are 16 drugs in the patent and exclusivity list. They are: - UNITED THERAPEUTICS CORP's REMODULIN, containing active ingredient TREPROSTINIL - VALINOR PHARMA LLC's MOVANTIK, containing active ingredient NALOXEGOL OXALATE - OTSUKA PHARMACEUTICAL CO LTD's ABILIFY, containing active ingredient ARIPIPRAZOLE - INTRA-CELLULAR THERAPIES INC's CAPLYTA, containing active ingredient LUMATEPERONE TOSYLATE - PFIZER INC's TOVIAZ, containing active ingredient FESOTERODINE FUMARATE - CUBIST PHARMACEUTICALS LLC's ZERBAXA, containing active ingredient CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM - EISAI INC's LENVIMA, containing active ingredient LENVATINIB MESYLATE - PF PRISM CV's BOSULIF, containing active ingredient BOSUTINIB MONOHYDRATE - AMGEN INC's OTEZLA, containing active ingredient APREMILAST Read More

This week, there are 9 drugs in the patent and exclusivity list. They are: - SANDOZ INC's HYCAMTIN, containing active ingredient TOPOTECAN HYDROCHLORIDE - MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC's ZEPATIER, containing active ingredient ELBASVIR; GRAZOPREVIR - NOVARTIS PHARMACEUTICALS CORP's KISQALI FEMARA CO-PACK (COPACKAGED), containing active ingredient LETROZOLE; RIBOCICLIB SUCCINATE - NOVARTIS PHARMACEUTICALS CORP's KISQALI, containing active ingredient RIBOCICLIB SUCCINATE - SAREPTA THERAPEUTICS INC's VYONDYS 53, containing active ingredient GOLODIRSEN - ABBVIE INC's RINVOQ, containing active ingredient UPADACITINIB - PFIZER INC's XELJANZ XR, containing active ingredient TOFACITINIB CITRATE - PF PRISM CV's XELJANZ, containing active ingredient TOFACITINIB CITRATE - CALLIDITAS THERAPEUTICS AB's TARPEYO, containing active ingredient BUDESONIDE Read More

This week, there are 1 drug in the patent and exclusivity list. It is: - ORGANON LLC's XACIATO, containing active ingredient CLINDAMYCIN PHOSPHATE Read More

This week, there are 3 drugs in the patent and exclusivity list. They are: - ABBVIE INC's ACULAR LS, containing active ingredient KETOROLAC TROMETHAMINE - FRESENIUS KABI USA LLC's DIPRIVAN, containing active ingredient PROPOFOL - GLOBAL BLOOD THERAPEUTICS INC's OXBRYTA, containing active ingredient VOXELOTOR Read More

This week, there are 8 drugs in the patent and exclusivity list. They are: - KALEO INC's AUVI-Q, containing active ingredient EPINEPHRINE - NOVO NORDISK INC's VICTOZA, containing active ingredient LIRAGLUTIDE - NOVO NORDISK INC's SAXENDA, containing active ingredient LIRAGLUTIDE - BRISTOL MYERS SQUIBB's REVLIMID, containing active ingredient LENALIDOMIDE - CUMBERLAND PHARMACEUTICALS INC's CALDOLOR, containing active ingredient IBUPROFEN - AMERICAN REGENT INC's INJECTAFER, containing active ingredient FERRIC CARBOXYMALTOSE - ALNYLAM PHARMACEUTICALS INC's GIVLAARI, containing active ingredient GIVOSIRAN SODIUM - AADI BIOSCIENCE INC's FYARRO, containing active ingredient SIROLIMUS Read More